MedTrace Logo

Compass Device CVC Trial

NCT03056859 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-06-27

Study results available
· View outcomes & findings →

Summary

This is a single-arm observational trial of a device (Compass Vascular Access, Centurion Medical Products, Williamston MI). The device is a compact, sterile, single-use extravascular blood pressure transducer. This pressure measurement aids in confirmation of appropriate venous access. The investigators plan to enroll 40 consenting patients with BMI ≥35 who require central venous catheterization for clinical reasons independent of the existence of this study. The primary outcome is operator satisfaction.

Conditions

  • Blood Pressure

Interventions

DEVICE

Extravascular blood pressure transducer

Listed device is included in central venous catheter placement apparatus for consenting patients, according to manufacturer directions

Sponsors & Collaborators

  • Centurion Medical Products

    collaborator INDUSTRY

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Neal Gerstein, MD · University of New Mexico School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-17
Primary Completion
2020-02-10
Completion
2020-02-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03056859 on ClinicalTrials.gov